GILD
Gilead SciencesCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
GILD vs peer average
42/100
GILD vs. peer average (C vs. B)
Grade spread
A 1 · B 4 · C 4 · D 1
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
ABBV is the first available peer comparator.
Large specialty biopharma with comparable commercial scale and durable franchise management; useful benchmark for margins, cash return, and franchise longevity.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
GILD
Gilead Sciences
ABBV
AbbVie
Grade
C
B
Momentum
35
51
Value
64
62
Sentiment
61
54
Setup Bias
Net Bullish
-
Market Cap
-
-
Posture
Mixed
Constructive
Grade position vs ABBV
GILD / ABBV
Grade Position
Below peers
GILD vs. peer average (C vs. B)
42/100
Momentum
35
ABBVValue
64
GILDSentiment
61
GILDRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs GILD
ABBV is the first peer returned for this comparison set.

